Table 1.
Demographic and clinical characteristics of HP donors.
| Variable | Non-fibrotic HP n = 7 | Fibrotic HP n = 13 | p-value |
|---|---|---|---|
| Age (years) | 61 ± 10 | 59 ± 8 | 0.48 |
| Gender (M/F) | 1 / 6 | 4 / 9 | 0.61 |
| Active smoker | 1 | 6 | 0.328 |
| FVC % predicted (SD) | 62 ± 19 | 63 ± 17 | 0.697 |
| DLCO % predicted (SD) | 48 ± 18 | 55 ± 17 | 0.812 |
| SpO2 (SD) | 94.5 ± 0.03 | 89 ± 7 | < 0.0001 |
Patients were classified as fibrotic or non-fibrotic following the Official ATS/JRS/ALAT Clinical Practice Guideline2. Tests were performed at 2440mts of altitude. Numbers in age and functional tests are presented as average ± standard deviation.
FVC forced vital capacity, DLCO diffusing lung capacity for carbon monoxide, SpO2 oxygen saturation at rest, HP Hypersensitivity pneumonitis, M male, F female, SD standard deviation.